3/27
01:29 pm
tbph
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report? [Yahoo! Finance]
3/21
06:09 am
tbph
TOLREMO Appoints Industry Veterans Jeff Jonker and Mike Sherman to Board of Directors [Yahoo! Finance]
Low
Report
TOLREMO Appoints Industry Veterans Jeff Jonker and Mike Sherman to Board of Directors [Yahoo! Finance]
2/28
10:46 am
tbph
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/26
04:09 pm
tbph
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
2/26
04:05 pm
tbph
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Neutral
Report
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2/22
06:10 am
tbph
Theravance Biopharma to Participate in an Upcoming Investor Conference [Yahoo! Finance]
Low
Report
Theravance Biopharma to Participate in an Upcoming Investor Conference [Yahoo! Finance]
2/22
06:00 am
tbph
Theravance Biopharma to Participate in an Upcoming Investor Conference
Low
Report
Theravance Biopharma to Participate in an Upcoming Investor Conference
2/15
07:19 am
tbph
Will Theravance Biopharma (NASDAQ:TBPH) Spend Its Cash Wisely? [Yahoo! Finance]
Medium
Report
Will Theravance Biopharma (NASDAQ:TBPH) Spend Its Cash Wisely? [Yahoo! Finance]
2/14
06:00 am
tbph
Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
Low
Report
Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
1/19
06:13 am
tbph
Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long [Yahoo! Finance]
Low
Report
Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long [Yahoo! Finance]
1/12
11:28 am
tbph
Down -11.17% in 4 Weeks, Here's Why Theravance Bio (TBPH) Looks Ripe for a Turnaround [Yahoo! Finance]
Low
Report
Down -11.17% in 4 Weeks, Here's Why Theravance Bio (TBPH) Looks Ripe for a Turnaround [Yahoo! Finance]
1/8
08:49 am
tbph
Theravance Biopharma, Inc. (NASDAQ: TBPH) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating.
Low
Report
Theravance Biopharma, Inc. (NASDAQ: TBPH) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating.
1/5
06:19 am
tbph
Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) [Yahoo! Finance]
High
Report
Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) [Yahoo! Finance]
1/5
06:00 am
tbph
Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Medium
Report
Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)